Revolutionary Wearable Ultrasound Device Gains FDA Approval

Manamed, a pioneering Medical Technology development company, has been granted FDA approval on its latest orthopedic recovery device, ManaSport.

LAS VEGAS, May 26, 2022 /PRNewswire/ -- ManaMed (ManaMed.com) is proud to announce the U.S. Food and Drug Administration (FDA) approval for the ManaSport™ ultrasound therapy Class II device. The ManaSport device, is a new ultrasound therapy device that provides pain relief and treatment for soft-tissue injuries and is popular among athletes and sports professionals. Safe and easy to use, the new device is set to offer life-changing support to those suffering from ongoing issues. FDA approval has now cleared the product for a range of indications for use, including:

Chronic pain relief.
Muscle spasms and joint contractures.
Relief from pain and joint contractures associated with adhesive capsulitis, bursitis with slight calcification, myositis, soft tissue injuries, and shortened tendons from past injuries and scar tissue.
Relief from pain and muscle spasms resulting from capsular tightness and capsular scarring.
Increasing localized blood flow.
Increasing the range of motion of contracted joints with heat and stretch techniques.

Portable and rechargeable, the device can now be prescribed by medical professionals and is intended for supervised use. It provides non-invasive pulsed ultrasound therapy at localized sites through ultrasound gel, with no discomfort to the patient. A complete therapy session takes just 20 minutes, and the product comes complete with everything you need to carry out therapy sessions, including ultrasound gel, a strap to hold the applicator in place, and a battery charger.

This compact medical device has an intuitive display with simple instructions for use. A built-in calendar helps users stay on top of treatments, while special safety features can lock the device to avoid unintended operation. Physicians and physiotherapists can manually move the applicator throughout the affected area, or use the included strap for a static, hands-free treatment.

Put simply, ManaSport provides a straightforward and effective solution for many medical and sports related issues and conditions, without the need for surgery or opioids. With the new FDA approval, ManaSport is sure to become the go-to therapy for sports medicine doctors everywhere.

Trevor Theriot, President, and CEO commented, “ManaMed will continue to design, develop, and innovate the entire Med Tech space. ManaSport demonstrates our commitment to invest in the future and expand our access to the entire continuum of care.”

ABOUT MANAMED
ManaMed is a pioneer of designing, developing, and manufacturing innovative medical devices. The company offers a wide range of orthopedic solutions for both physician and patient needs, ranging from bracing to vascular therapy devices, assisted mobility devices, electrical stimulation, maternity, and DVT prevention products. With extensive product and innovative offerings, ManaMed provides medical technology solutions to address the patient’s continuum of care from performance and mobility to post-operative rehabilitation. For over seven years ManaMed has been creating products that help people get back on their feet after injury or surgery, enabling them to stay active longer. For more information, please contact support@manamed.com, 888-508-0712.

Recently named as the official partner of the UFC Performance Institute, ManaMed is set to become the world’s leading provider of high-performance orthopedic devices, with a commitment to continued innovation.

For more information, please contact support@manamed.com, 888-508-0712.

View original content to download multimedia:https://www.prnewswire.com/news-releases/revolutionary-wearable-ultrasound-device-gains-fda-approval-301555292.html

SOURCE ManaMed Inc.